Visualitza per autor "Hara, Hiroki"
Ara mostrant els elements 1-1 d 1
-
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Le, Dung T.; Kim, Tae Won; Van Cutsem, Eric; Geva, Ravit; Jäger, Dirk; Hara, Hiroki; Elez Fernandez, Mª Elena (American Society of Clinical Oncology, 2020-01-01)